Back to Search
CHARLES LEVEA, MD PHD
MD PHD
Anatomic Pathology & Clinical Pathology Physician
NPI: 1730187006IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
207512(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.
PMID 15194442·Exp Cell Res·2004
8-other
PTP LAR expression compared to prognostic indices in metastatic and non-metastatic breast cancer.
PMID 11194458·Breast Cancer Res Treat·2000
7-preclinical
The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer.
PMID 19524264·J Surg Res·2009
7-preclinical
Spontaneous regression of colorectal cancer metastatic to retroperitoneal lymph nodes.
PMID 19331187·Anticancer Res·2009
5-case
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.
PMID 19235592·Cancer Invest·2009
3-trial
Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma.
PMID 19224914·J Biol Chem·2009
7-preclinical
Significance of signet-ring cells in patients with colorectal cancer.
PMID 18030531·Dis Colon Rectum·2008
8-other
Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.
PMID 18845990·Am J Clin Oncol·2008
3-trial
Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.
PMID 18565686·Int J Radiat Oncol Biol Phys·2008
3-trial
Characterization of HCT116 human colon cancer cells in an orthotopic model.
PMID 17961596·J Surg Res·2008
7-preclinical
Epidermal growth factor receptor-directed therapy in esophageal cancer.
PMID 18477853·Oncology·2007
6-review
Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model.
PMID 17575153·Cancer Res·2007
4-observational
Reversible grade 4 hyperbilirubinemia in a patient with UGT1A1 7/7 genotype treated with irinotecan and cetuximab.
PMID 17531109·Clin Colorectal Cancer·2007
5-case
CD24 expression is an independent prognostic marker in cholangiocarcinoma.
PMID 17436128·J Gastrointest Surg·2007
8-other
COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
PMID 17146741·Ann Surg Oncol·2007
8-other
Gastrointestinal stromal tumor: chondro-myxoid variant mimicking chondrosarcoma.
PMID 18521413·Sarcoma·2005
8-other
Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma.
PMID 16110118·Int J Gastrointest Cancer·2005
8-other
Anaplastic pancreatic carcinoma. A case report and review of literature .
PMID 15536293·JOP·2004
5-case
The leukocyte common antigen-related protein LAR: candidate PTP for inhibitory targeting.
PMID 12678846·Curr Top Med Chem·2003
6-review
Expression of the leucocyte common antigen-related (LAR) tyrosine phosphatase is regulated by cell density through functional E-cadherin complexes.
PMID 12095414·Biochem J·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- ELM AND CARLTON ST
BUFFALO, NY 14263 - Phone
- (716) 845-2300
Quick Facts
- NPI
- 1730187006
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile